Showing 1551-1560 of 1635 results for "".
- Study: Vision Loss Has Significant Impact on Use of Hospital Resources and Costs for Older Patientshttps://modernod.com/news/study-vision-loss-has-significant-impact-on-use-of-hospital-resources-and-costs-for-older-patients/2476440/A national study has found that older patients with vision loss who are hospitalized for common disorders are often not identified as requiring special attention, which can affect outcomes, resource use, and costs. The study is published in the April 4 issue o
- Arkansas Secures Expanded Scope of Practicehttps://modernod.com/news/arkansas-secures-expanded-scope-of-practice/2479581/As advocates nationwide work to advance optometry’s future-focused role in health care, Arkansas becomes the latest state enacting scope of practice expansion to include surgical procedures, according to the American Optometric Association. Signed into law March 27 by Gov. Asa Hutch
- Mary Lynch, MD, Receives Innovator Award from the American Glaucoma Societyhttps://modernod.com/news/mary-lynch-md-receives-innovator-award-from-the-american-glaucoma-society/2476419/The American Glaucoma Society has named Emory Eye Center ophthalmologist Mary G. Lynch, MD, as the 2019 recipient of the society’s prestigious Innovator Award. The award is given to one physician each year in recognition of his or her contributions to the field of glaucoma. She is the first woman
- Lilliana Vazquez to Moderate Vision Expo’s EYE2EYE Series with Commonhttps://modernod.com/news/lilliana-vazquez-to-moderate-vision-expos-eye2eye-series-with-common/2476392/Vision Expo has announced Lilliana Vazquez will moderate its inaugural EYE2EYE series with award-winning artist Common. Ms. Vazquez is a multi-media personality that has acted as a host, influencer, style advisor and producer for the biggest names in entertainment, including working as a contribu
- Nicox Initiates Phase 2 Trial of NCX 4251 in Blepharitishttps://modernod.com/news/nicox-initiates-phase-2-trial-of-ncx-4251-in-blepharitis/2476393/Nicox SA announced the initiation of a phase 2 clinical trial evaluating NCX 4251, its novel patented ophthalmic suspension of fluticasone propionate nanocrystals, being developed as the first targeted topical treatm
- GenSight Biologics to Present 72-Week Data From the REVERSE Phase 3 Trial of GS010https://modernod.com/news/gensight-biologics-to-present-72-week-data-from-the-reverse-phase-3-trial-of-gs010/2476389/GenSight Biologics announced that the 72-week results from the REVERSE Phase 3 clinical trial of GS010 will be presented at the 45th Annual Meeting of the North American Neuro-Ophthalmology Society (NANOS), which will be held in Las Vegas from March 16 to 21, 2019. The results will be presented b
- Alcon Acquires Fluid-Based IOL Maker PowerVisionhttps://modernod.com/news/alcon-announces-acquisition-of-powervision/2476387/Alcon announced that it has acquired PowerVision for $285 million plus regulatory and milestone payments starting in 2023. PowerVision’s lens design utilizes the eye’s natural accommodating response to transport fluid in the IOL. While most presbyopia-correcting IOLs use a mult
- Dompé Receives Industry Innovation Award for Oxervate Eye Drops for Neurotrophic Keratitishttps://modernod.com/news/dompe-receives-industry-innovation-award-for-oxervate-eye-drops-for-neurotrophic-keratitis/2476372/Dompé Farmaceutici S.p.A and Dompé US Inc. announced that the National Organization for Rare Disorders (NORD) has awarded them the 2019 Industry Innovation Award for Oxervate. The Rare Impact Awards celebrate people, organizations, and innovators making exceptional contributions benefiting rare d
- Prevent Blindness Announces Recipient of 2019 Jenny Pomeroy Award for Excellence in Vision and Public Healthhttps://modernod.com/news/prevent-blindness-announces-recipient-of-2019-jenny-pomeroy-award-for-excellence-in-vision-and-public-health/2476374/Prevent Blindness has announced the recipient of the 2019 Jenny Pomeroy Award for Excellence in Vision and Public Health is Cynthia Owsley, PhD, MSPH, Nathan E. Miles Chair of Ophthalmology and Director of the Clinical Research Unit at the University of Alabama at Birmingham (UAB) School of Medic
- Clemson Eye Integrates Two Greenville Eye Care Practices into Its Networkhttps://modernod.com/news/clemson-eye-integrates-two-greenville-eye-care-practices-into-its-network/2476368/This spring, Clemson Eye will unite with two Greenville eye health practices — Montgomery & Riddle Eyecare and Donelson Eye Associates — under the Clemson Eye brand name. Combined, the practices serve more than 100,000 patients and offer more than 10 specialties. “This transition is a